Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

Announcement on Subsidiary’s TFA003 Tablets Obtaining the Notice of Approval for Drug Clinical Trials

· Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary’s TFA003 Tablets Obtaining the Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment